These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4082825)

  • 1. In vitro susceptibility to antibiotics and sulfonamides of atypical mycobacteria isolated in South America.
    de Kantor IN; Barrera L; di Lonardo M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):247-53. PubMed ID: 4082825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A drug sensitivity test strategy for atypical mycobacteria.
    Hejný J
    Tubercle; 1982 Mar; 63(1):63-9. PubMed ID: 7082424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of Mycobacterium fortuitum to non-antituberculous antibacterial agents.
    Casal MJ; Rodriguez FC
    Ann Microbiol (Paris); 1983; 134A(1):73-8. PubMed ID: 6847037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of ciprofloxacin against clinical isolates of mycobacteria resistant to antimycobacterial drugs.
    Marinis E; Legakis NJ
    J Antimicrob Chemother; 1985 Oct; 16(4):527-30. PubMed ID: 2933382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycobacterial bases of the therapy of mycobacterioses].
    Hejný J
    Z Erkr Atmungsorgane; 1982; 158(1-2):163-7. PubMed ID: 7072265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for determining the antimicrobial susceptibility of mycobacteria.
    Alcaide F; Esteban J; González-Martin J; Palacios JJ
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):529-535. PubMed ID: 27236235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Susceptibility of Non-tuberculous Strains of
    Ledwoń A; Napiórkowska A; Augustynowicz-Kopeć E; Szeleszczuk P
    Pol J Microbiol; 2018; 67(4):487-492. PubMed ID: 30550235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro study of the susceptibility of mycobacteria to sulfonamides by the disc and percentage methods (author's transl)].
    Demoulin L; Médard M; Kellens J
    Pathol Biol (Paris); 1982 Apr; 30(4):201-5. PubMed ID: 7045778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification and drug susceptibility testing of
    Li WB; Ji LY; Xu DL; Liu HC; Zhao XQ; Wu YM; Wan KL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):669-672. PubMed ID: 29860815
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real time PCR for the rapid identification and drug susceptibility of Mycobacteria present in Bronchial washings.
    Keerthirathne TP; Magana-Arachchi DN; Madegedara D; Sooriyapathirana SS
    BMC Infect Dis; 2016 Oct; 16(1):607. PubMed ID: 27782812
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antibiotics, resorcinomycins A and B: antibacterial activity of resorcinomycin A against mycobacteria in vitro.
    Masaki S; Konishi T; Tsuji N; Shoji J
    J Antibiot (Tokyo); 1989 Mar; 42(3):463-6. PubMed ID: 2708139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.
    Stone MS; Wallace RJ; Swenson JM; Thornsberry C; Christensen LA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):486-93. PubMed ID: 6651277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].
    Ceyhan İ; Özkara Ş; Güler MZ; Dulkar G; Altınsoy R; Vezir S
    Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation-drug resistance profile and molecular characterization of indigenous typical and atypical mycobacteria.
    Khanum T; Rasool SA; Ajaz M; Khan AI
    Pak J Pharm Sci; 2011 Oct; 24(4):527-32. PubMed ID: 21959816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
    Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N
    Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved isolation of mycobacteria other than Mycobacterium tuberculosis on isoniazid-containing Löwenstein-Jensen medium.
    Miörner H; Olsson B
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):47-9. PubMed ID: 3132376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Jones DB; Wiss K
    Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.